Please login to the form below

Not currently logged in
Email:
Password:

Sudler & Hennessey cofounder dies

Matt Hennessey, one of Sudler & Hennessey's (S&H) cofounders has died of cancer at the age of 95

Matt Hennessey, one of Sudler & Hennessey's (S&H) cofounders has died of cancer at the age of 95.

Matthew Joseph Hennessey was born in 1916, in Brooklyn, New York. Hennessey began his art career in 1936, working with Arthur Sudler in his graphic design studio where Sudler set up shop with E R Squibb and Sons as his charter client. Five years later, they founded Sudler & Hennessey, with Hennessey as president and Sudler as chairman.

Art directors hired by Hennessey included George Lois, Helmut Krone, Ernie Smith, Herb Lubalin, Charles Addams, Ronald Searle, and Andy Warhol.

Hennessey was a believer in the power of visual communication, and it was at the helm when the original NBC peacock was created by S&H.

After serving in the army during World War II, Hennessey returned to the agency and, in 1953, made the decision to focus on the pharmaceutical industry. By 1968, S&H was the largest medical agency and held that distinction for more than 20 years.

After Art Sudler passed away, Sudler & Hennessey became part of Young & Rubicam, now with a network that spans the globe. Hennessey was inducted into the Medical Advertising Hall of Fame in 1998.

Jed Beitler, chairman and CEO worldwide, S&H, said: "Matt retired in 1984, but his legacy to the business world lives on. His vision helped to lay the foundation for the success S&H enjoys today on a global scale."

26th April 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...